Clinical Trials Browser

Phase 1/2 × INDUSTRY × Fibroblast Growth Factor 7 × Clear all

NCT00626639 2017-06-21

A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy

Phase 1/2 Completed

5 enrolled 8 charts

Head & NeckOther

Head and Neck Neoplasms, Neoplasms, Mucositis

NCT00540332 2009-03-02

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy

Phase 1/2 Withdrawn

Head and Neck Neoplasms, Neoplasms, Stomatitis